ARAV logo

Aravive, Inc. Common Stock


ARAV: Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials.


Show ARAV Financials

Consumer Interest
SEC Filings

Recent trades of ARAV by members of U.S. Congress

Recently reported changes by institutional investors

Quarterly net insider trading by ARAV's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ARAV in WallStreetBets Daily Discussion


Recent insights relating to ARAV

CNBC Recommendations

Recent picks made for ARAV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ARAV

Corporate Flights

Flights by private jets registered to ARAV